Oncology and Hematology

Episodes 1-16 of 150

- Daniel Catenacci, MD
  Peer
- Yelena Janjigian, MD
  Peer
0
CME/CE
Advanced HER2-Positive Gastric Cancer
Advanced HER2-Positive Gastric Cancer
0.25 credits
Advanced HER2-Positive Gastric Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Ana Oaknin, MD
  Peer
0
CME/CE
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
0.25 credits
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cance...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Nicoletta Colombo, MD
  Peer
- Christine Ghione
  Peer
0
CME/CE
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
- Paul Paik, MD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
0
CME/CE
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
0.25 credits
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrat...
0.25 credits
- Jennifer Caudle, DO
  Peer
- Stephen Liu, MD
  Peer
2
Closing the Gaps in NSCLC
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Ca...
- Paul P. Doghramji, MD, FAAFP
  Peer
- Edward S. Kim, MD
  Peer
1
Closing the Gaps in NSCLC
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
- Stephen Liu, MD
  Peer
1
Closing the Gaps in NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Current & Future Innovations in Lung Cancer Detection
Current & Future Innovations in Lung Cancer Detection
Current & Future Innovations in Lung Cancer Detection
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Investigating a Potential Serum Biomarker for Lung Cancer
Investigating a Potential Serum Biomarker for Lung Cancer
Investigating a Potential Serum Biomarker for Lung Cancer
- Amit Bobby Mahajan, MD, FCCP, DAABIP
  Peer
0
Closing the Gaps in NSCLC
NSCLC State of the Union: Where We Are & Where We're Going
NSCLC State of the Union: Where We Are & Where We're Going
NSCLC State of the Union: Where We Are & Where We're Going
- Monica L. Baskin, PhD
  Peer
- Josep M. Llovet, MD, PhD
  Peer
2
CME/CE
Advocating for Action in HCC: Delivering Impartial and Personalized Care
Advocating for Action in HCC: Delivering Impartial and Personalized Care
1.00 credits
Advocating for Action in HCC: Delivering Impartial and Personalized Care
1.00 credits
- Floor J. Backes, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
9
CME/CE
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
0.25 credits
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
0.25 credits
- Federico Cappuzzo
  Peer
- Professor Solange Peters
  Peer
- Professor Yi-Long Wu
  Peer
1
CME/CE
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
0.25 credits
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global A...
0.25 credits